Not Yet RecruitingNot Applicable

Respiratory Disease Cohort Studies of Chinese Medicine for COPD(RESEARCH-COPD)

China10,000 participantsStarted 2024-10-01

Plain-language summary

This study will establish a registration research platform, a clinical research database and a biospecimen bank for the prevention and treatment of COPD with Chinese medicine. Based on the COPD registry database, a cohort of Chinese medicine for COPD prevention and treatment will be established.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Meets diagnostic criteria for chronic obstructive pulmonary disease (COPD) or preserved ratio impaired spirometry (PRISm). * Age ranges from 18 years to 80 years. * The investigators agreed to participate in this clinical study by voluntarily signing an informed consent form. Exclusion Criteria: * Patients with delirium, dementia, various mental illnesses. * Pregnant and planned pregnant or lactating women. * Patients with other serious systemic diseases. * Patients who, in the opinion of the investigator, are not suitable for participation in this study.

What they're measuring

Frequencies of acute exacerbations (AEs)

Timeframe: Frequency of acute exacerbations at months 3, 6, 9, 12, 15, 18, 21, and 24.

Incidence of COPD

Timeframe: 24 months after enrollment.

Trial details

NCT IDNCT06577701

SponsorHenan University of Traditional Chinese Medicine

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2027-04-30

Contact for this trial

Yang Xie, Ph.D

13526621325 xieyanghn@163.com

View on ClinicalTrials.gov More Chronic Obstructive Pulmoriary Disease (COPD) trials